Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
Holding CTOR?
Track your performance easily

Citius Oncology (CTOR) Income Statement

44 Followers

Citius Oncology Income Statement

Last quarter (Q ), Citius Oncology's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Citius Oncology's net income was $252.46K. See Citius Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Dec 22Dec 21
Total Revenue
--$ 0.00$ 0.00
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 522.07K$ 12.12M$ 138.12K$ 10.11K
Operating Income
$ -522.07K$ -12.12M$ -138.12K$ -10.11K
Net Non Operating Interest Income Expense
--$ 493.02K-
Other Income Expense
$ -636.42K-$ 25.91K-
Pretax Income
$ 633.27K$ -12.12M$ 380.81K$ -10.11K
Tax Provision
-$ 576.00K--
Earnings From Equity Interest Net Of Tax
$ 636.42K---
Net Income Common Stockholders
$ 633.27K$ -12.70M$ 380.81K$ -10.11K
Basic EPS
$ 0.04$ -0.19-$ >-0.01
Diluted EPS
$ 0.04$ -0.19-$ >-0.01
Basic Average Shares
$ 4.31M$ 67.50M-$ 8.94M
Diluted Average Shares
$ 2.34M$ 67.50M-$ 8.94M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 522.07K$ 12.12M$ 138.12K$ 10.11K
Net Income From Continuing And Discontinued Operation
$ 633.27K$ -12.70M$ 380.81K$ -10.11K
Normalized Income
$ 630.75K$ -8.91M$ 365.27K$ -10.11K
Interest Expense
----
EBIT
$ 114.35K$ -12.12M$ -138.12K$ -10.11K
EBITDA
$ 114.35K$ -12.12M$ -138.12K$ -10.11K
Currency in USD

Citius Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis